Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. EOS imaging
  6. News
  7. Summary
    EOSI   FR0011191766

EOS IMAGING

(EOSI)
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Alphatec Holdings, Inc. and Eos Imaging Sa to Improve the Predictability of the Patient Experience in Spine from Diagnosis Through Follow Up

06/07/2021 | 09:00am EDT

Alphatec Holdings, Inc. welcomes the EOS imaging (Paris:EOSI) team in a combination forged to improve the predictability of the patient experience in spine from diagnosis through follow up. Combining ATEC with EOS, the recognized global leader in full-body, 2D/3D spine imaging solutions, will create new treatment standards in spine through: REFLECTING THE TECHNOLOGY’S VALUE. The two U.S. sales forces will be aligned to create a capital and spine hardware distribution network. The team will extend the clinical value of EOS technology to both customer bases and introduce EOSedge™, the next-generation platform recently launched by EOS. Capable of full-body and localized imaging that delivers superior image resolution, EOSedge further optimizes radiation dose and has a fully redesigned, open architecture that significantly expands the applications for EOS in adults and children. INFORMING. The value of EOS extends well beyond imaging. The ability to obtain an unbiased, calibrated full-body image will enable a 3D model of patients’ skeletal systems and provide unprecedented diagnostic and surgical planning capabilities. The integration of ATEC’s approach-specific solutions into EOS’s 3D surgical planning platform can better inform surgery and enhance the predictability of outcomes by allowing surgeons to more effectively assess the patient’s full body alignment, establish surgical objectives, and simulate surgery with optimized implants. Additionally, over time, this information will distinguish ATEC with an unrivalled ability to deliver more customized instrument and implant configurations into surgery, reducing inefficiencies. INFLUENCING. Over the intermediate term, the technological foundation of the EOSedge platform will be further developed, facilitating an unprecedented ability to reliably measure bone quality at each vertebral segment. Coupling that information with an increasingly sophisticated 3D alignment and surgical planning platform will support the design and delivery of patient-specific implants, effecting highly customized patient care. PREDICTING. Spine surgery is exceedingly complex. No surgical specialty has more variables that can meaningfully impact a patient’s short and long-term outcomes. EOS’ data collection initiatives will be advanced, enabling the creation and refinement of predictive algorithms over time. Predictive models will provide surgeons with critical information throughout the planning phase to more precisely determine the surgical approach with the highest probability for a successful outcome.


ę S&P Capital IQ 2021
All news about EOS IMAGING
06/14EOS IMAGING : Opening of a period of early redemption for the bondholders from June 14 to ..
PU
06/07Alphatec Holdings, Inc. and Eos Imaging Sa to Improve the Predictability of the Patient..
CI
05/18EOS imaging SA Announces Board Changes
CI
05/13Alphatec Holdings, Inc. completed the acquisition of EOS imaging SA.
CI
05/11EOS IMAGING SA(ENXTPA : EOSI) dropped from CAC Small Index
CI
04/21GLOBAL MARKETS LIVE : Ericsson, Netflix, Roche...
04/20EOS IMAGING : corporate presentation - April 2021
PU
04/20Eos Imaging Sa Reports Earnings Results for the Full Year Ended December 31, 2020
CI
04/20EOS IMAGING : 1st quarter earnings
CO
04/20EOS IMAGING : Annual results
CO
More news
Financials
Sales 2020 26,0 M 30,5 M 30,5 M
Net income 2020 -11,2 M -13,1 M -13,1 M
Net Debt 2020 20,1 M 23,5 M 23,5 M
P/E ratio 2020 -5,52x
Yield 2020 -
Capitalization 65,2 M 78,8 M 76,4 M
EV / Sales 2019 3,66x
EV / Sales 2020 3,14x
Nbr of Employees 157
Free-Float 4,26%
Chart EOS IMAGING
Duration : Period :
EOS imaging Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Michael Charles Lobinsky Chief Executive Officer & Director
ValÚrie Worrall Chief Financial Officer
GÚrard HascoŰt Chairman
Elisabeth Soubelet Chief Medical Officer
Maurice Delplanque Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
EOS IMAGING5.60%79
THERMO FISHER SCIENTIFIC30.58%239 899
DANAHER CORPORATION46.32%231 660
INTUITIVE SURGICAL, INC.27.53%124 147
SIEMENS HEALTHINEERS AG42.12%78 408
EDWARDS LIFESCIENCES CORPORATION32.65%74 843